Acceptance and Commitment Therapy for Tobacco Cessation Among Psychiatric Partial Hospital Patients
1 other identifier
interventional
17
1 country
1
Brief Summary
People with serious mental illness are three times more likely to smoke cigarettes than people without mental illness. People with mental illness are less likely to be successful in quitting smoking than those without mental illness. Therefore, the healthcare community needs to find ways to get people with mental illness treatment to help them stop smoking. This study explores whether a treatment, called acceptance and commitment therapy, which is an affective therapy for serious mental illness, can help patients with serious mental illness stop smoking. In particular, the investigators test whether patients will be interested in receiving acceptance and commitment therapy for smoking cessation in a psychiatric partial hospital (also known as a day treatment program), whether they are able to complete the treatment, and whether it will help them stop smoking compared to usual care. To test these research questions, 40 patients in the Rhode Island Hospital's psychiatric partial hospital will be recruited. Half of the patients will receive acceptance and commitment therapy to help them stop smoking (2 in person sessions, 5 telephone sessions) and half will receive usual care (2 in person sessions, electronic referral to the Rhode Island tobacco quit line). All participants will be offered the nicotine patch. All participants will complete a baseline survey and a follow-up visit at the end of treatment to measure whether they stopped smoking and whether they liked the treatment. The study will also measure how many participants completed the treatment sessions. If successful, this treatment model could be a way to get more patients with mental illness into treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 26, 2019
CompletedFirst Posted
Study publicly available on registry
April 11, 2019
CompletedStudy Start
First participant enrolled
April 16, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 15, 2019
CompletedResults Posted
Study results publicly available
September 25, 2020
CompletedSeptember 25, 2020
January 1, 2019
7 months
March 26, 2019
September 1, 2020
September 23, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Feasibility of Recruitment: Proportion of Smokers Seen During the Partial Hospital Visit Who Enroll in the Study
proportion of smokers seen during the partial hospital visit who enroll in the study
Through study completion, approximately 5 months.
Percentage of Counseling Sessions Completed
number of scheduled counseling sessions completed
through study completion, an average of 7 weeks.
Client Satisfaction Questionnaire
The Client satisfaction Questionnaire, measures acceptability of the intervention to patients, minimum value=8, maximum value=32, higher scores indicate higher satisfaction (higher scores mean better outcome)
at study completion, an average of 7 weeks post-enrollment
Number of Participants Who Are Rehospitalized for Psychiatric Reasons
This is a simple count based on follow-up survey data of the number of participants who reported being hospitalized for a psychiatric reason following enrollment in the study.
At study completion, an average of 7 weeks post enrollment
Secondary Outcomes (2)
Number of Participants Who Are Abstinent From Tobacco
at study completion, an average of 7 weeks post enrollment
Kessler 6
Change between baseline and study completion, 7 weeks post-enrollment
Other Outcomes (2)
Avoidance Inflexibility Scale
Change between baseline and study completion, 7 weeks post-enrollment
Commitment to Quitting Scale
Change between baseline and study completion, 7 weeks post-enrollment
Study Arms (2)
Acceptance and Commitment Therapy
EXPERIMENTAL2 in person and 5 telephone sessions of Acceptance and Commitment Therapy for tobacco cessation plus up to 8 weeks of nicotine patch.
Enhanced Usual Care
ACTIVE COMPARATOR2 in-person sessions of tobacco cessation counseling, electronic referral to state quitline, up to 8 weeks of nicotine patch
Interventions
2 in person and 5 telephone sessions of acceptance and commitment therapy for tobacco cessation plus up to 8 weeks of nicotine patch
2 in person sessions of tobacco cessation counseling, up to 8 weeks of nicotine patch, referral to state quitline.
Eligibility Criteria
You may qualify if:
- Participants will be male and female
- psychiatry partial hospital patients
- current daily smokers
- ≥ age 18
- have regular telephone access
- able to read and write English
You may not qualify if:
- current use of tobacco cessation treatment (bupropion prescribed for a psychiatric indication will be permitted)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Miriam Hospital
Providence, Rhode Island, 02906, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Sandra Japuntich
- Organization
- Hennepin Healthcare
Study Officials
- PRINCIPAL INVESTIGATOR
Sandra Japuntich, Ph.D.
Hennepin Healthcare Research Institute
- PRINCIPAL INVESTIGATOR
Ernestine Jennings, Ph.D.
The Miriam Hospital
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 26, 2019
First Posted
April 11, 2019
Study Start
April 16, 2019
Primary Completion
November 15, 2019
Study Completion
November 15, 2019
Last Updated
September 25, 2020
Results First Posted
September 25, 2020
Record last verified: 2019-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- within 18 months of study completion
- Access Criteria
- ethical guidelines for The Miriam Hospital will be followed (the investigator will have completed a research ethics training course and the data will be stored securely)
Only the Principal Investigator will give permission for the release of aggregated study data. No identifiable data will be released. Participants in the proposed research will be informed, during consent, that completely de-identified data (i.e., data that has been cleaned of all 18 types of HIPAA identifiers) will be available to other qualified researchers. Within 18 months of study completion, we will make datasets available to interested investigators who submit a written request to the PI. The only contingency on the use of the data will be that ethical guidelines be followed (e.g., only individuals who have completed a research ethics training course will have access to the data, the data will be stored securely). The NIH will be notified of transmissions of the data to interested investigators.